Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Neurosurgery

• Publication date

  1986-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1227/00006123-198610000-00011PMID 3097567
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Histological observations on the regrowth of malignant gliomas after radiotherapy and chemotherapy

  2004cited by this paper
• Developments in the diagnosis and treatment of primary CNS lymphoma: A prospective series

  1986cited by this paper
• Permeability of human brain tumor to 99mTc-gluco-heptonate and 99mTc-albumin. Implications for monoclonal antibody therapy.

  1986cited by this paper
• Growth of human lung tumor in the brain of the nude rat as a model to evaluate antitumor agent delivery across the blood-brain barrier.

  1985cited by this paper
• Childhood brain tumors: current status of clinical trials in newly diagnosed and recurrent disease.

  1985cited by this paper
• Glioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implications

  1985cited by this paper
• Osmotic blood-brain barrier modification: monoclonal antibody, albumin, and methotrexate delivery to cerebrospinal fluid and brain.

  1985cited by this paper
• Chemotherapeutic agent permeability to normal brain and delivery to avian sarcoma virus-induced brain tumors in the rodent: observations on problems of drug delivery.

  1984cited by this paper
• Osmotic blood-brain barrier modification and combination chemotherapy: concurrent tumor regression in areas of barrier opening and progression in brain regions distant to barrier opening.

  1984cited by this paper
• Karnofsky performance status revisited: reliability, validity, and guidelines.

  1984cited by this paper
• Elevated myelin basic protein levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia.

  1984cited by this paper
• Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma.

  1983cited by this paper
• Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas . A joint radiation therapy oncology group and eastern cooperative oncology group study

  1983cited by this paper
• Osmotic blood-brain barrier modification: clinical documentation by enhanced CT scanning and/or radionuclide brain scanning.

  1983cited by this paper
• Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme.

  1983cited by this paper
• Correlations between cytologic composition and biologic behavior in the glioblastoma multiforme. A postmortem study of 50 cases

  1983cited by this paper
• Successful treatment of primary central nervous system lymphomas with chemotherapy after osmotic blood-brain barrier opening.

  1983cited by this paper
• Permeability of Different Experimental Brain Tumor Models to Horseradish Peroxidase

  1982cited by this paper
• Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier.

  1982cited by this paper
• Pharmacology and toxicity of intracarotid adriamycin administration following osmotic blood-brain barrier modification.

  1981cited by this paper
• Neurologic sequelae of methotrexate and ionizing radiation: a new classification.

  1981cited by this paper
• Glioblastoma multiforme is not a uniform disease!

  1981cited by this paper
• Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption.

  1981cited by this paper
• A review of studies of the EORTC brain tumor group.

  1981cited by this paper
• Osmotic blood-brain barrier disruption in the posterior fossa of the dog.

  1981cited by this paper
• USE OF ENHANCED COMPUTERIZED TOMOGRAPHY TO EVALUATE OSMOTIC BLOOD–BRAIN BARRIER DISRUPTION

  1981cited by this paper
• Is there a therapeutic role for blood-brain barrier disruption?

  1980cited by this paper
• Effect of osmotic blood-brain barrier disruption on methotrexate pharmacokinetics in the dog.

  1980cited by this paper
• Dose: a critical factor in cancer chemotherapy.

  1980cited by this paper
• Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

  1980cited by this paper
• Brain tumor chemotherapy: an evaluation of agents in current use for phase II and III trials.

  1980cited by this paper
• Neuropsychologic impairment in astrocytoma survivors.

  1980cited by this paper
• Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy.

  1979cited by this paper
• Osmotic opening of the blood-brain barrier to methotrexate in the rat.

  1979cited by this paper
• High dose radiation therapy in the treatment of malignant gliomas: final report.

  1979cited by this paper
• Use of metrizamide computerized tomographic cisternography in the evaluation of patients with malignant glioma for immunotherapy.

  1979cited by this paper
• Chemotherapy of nonirradiated malignant gliomas. Phase II: Study of the combination of methyl‐CCNU, vincristine, and procarbazine

  1979cited by this paper
• Enhancement of CNS penetration of methotrexate by hyperosmolar intracarotid mannitol or carcinomatous meningitis

  1979cited by this paper
• The morphologic effects of radiation administered therapeutically for intracranial gliomas.A Postmortem study of 25 cases

  1979cited by this paper
• Capillary ultrastructure in human metastatic brain tumors.

  1979cited by this paper
• Management of central nervous system metastases.

  1977cited by this paper
• Chemotherapy of brain tumors.

  1977cited by this paper
• Disseminated necrotizing leukoencephalopathy: A complication of treated central nervous system leukemia and lymphoma

  1975cited by this paper
• The central nervous system in childhood leukemia. II. Subacute leukoencephalopathy

  1975cited by this paper
• Adriamycin chemotherapy—efficacy, safety, and pharmacologic basis of an intermittent single high‐dosage schedule

  1974cited by this paper
• Uptake and distribution of 3 H-methotrexate by the murine ependymoblastoma.

  1972cited by this paper
• Chemotherapy of brain tumors. Uptake of tritiated methotrexate by a transplantable intracerebral ependymoblastoma in mice.

  1972cited by this paper
• Experimental evaluation of potential anticancer agents. VI. Anatomical distribution of leukemic cells and failure of chemotherapy.

  1961cited by this paper
• Experimental study of contrast media for cerebral angiography with reference to possible injurious effects on the cerebral blood vessels.

  1949cited by this paper

• Deciphering Alzheimer's disease: Molecular mechanisms, preclinical models and strategies to overcome Blood-Brain-Barrier.

  2025cites this paper
• The curse of blood–brain barrier and blood–tumor barrier in malignant brain tumor treatment

  2025cites this paper
• Nanomedicine for Treating Major Brain Diseases: Advances and Future Directions.

  2025cites this paper
• Breaking Barriers in Neuro-Oncology: A Scoping Literature Review on Invasive and Non-Invasive Techniques for Blood–Brain Barrier Disruption

  2024cites this paper
• Delivery of Neuroregenerative Proteins to the Brain for Treatments of Neurodegenerative Brain Diseases

  2024cites this paper
• ABCB1 and ABCG2 Regulation at the Blood-Brain Barrier: Potential New Targets to Improve Brain Drug Delivery

  2023cites this paper
• Safety of intra-arterial chemotherapy with or without osmotic blood–brain barrier disruption for the treatment of patients with brain tumors

  2022cites this paper
• Influence of Acoustic Parameters and Sonication Schemes on Transcranial Blood–Brain Barrier Disruption Induced by Pulsed Weakly Focused Ultrasound

  2022cites this paper
• Neurosurgical Clinical Trials for Glioblastoma: Current and Future Directions

  2022cites this paper
• Central nervous system delivery of molecules across the blood-brain barrier.

  2021cites this paper
• Therapeutic Agent Delivery Across the Blood–Brain Barrier Using Focused Ultrasound

  2021cites this paper
• Targeting to the CNS: Approach for brain tumor

  2021cites this paper
• Strategies for Improved Intra-arterial Treatments Targeting Brain Tumors: a Systematic Review

  2020cites this paper
• Overcoming the blood-brain barrier in neurodegenerative disorders and brain tumours.

  2020cites this paper
• Drug targeting strategies into the brain for treating neurological diseases.

  2019cites this paper
• Stapled EGFR peptide reduces inflammatory breast cancer and inhibits additional HER-driven models of cancer

  2019cites this paper
• Focused ultrasound-mediated blood brain barrier disruption in the enhancement of delivery of brain tumor therapies.

  2019cites this paper
• Modeling hyperosmotic blood–brain barrier opening within human tissue-engineered in vitro brain microvessels

  2019cites this paper
• Novel Focal Treatment Modalities in Glioma Management

  2018cites this paper
• Challenges in the Treatment of Glioblastoma: Multisystem Mechanisms of Therapeutic Resistance.

  2018cites this paper
• Targeting Glioma Stem Cell-Derived Pericytes Disrupts the Blood-Tumor Barrier and Improves Chemotherapeutic Efficacy.

  2017cites this paper
• Principles of pharmacotherapy.

  2016cites this paper
• Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma.

  2016cites this paper
• Erratum to: Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study

  2016cites this paper
• The Blood-Brain Barrier in Glioblastoma: Pathology and Therapeutic Implications

  2016cites this paper
• The challenges associated with molecular targeted therapies for glioblastoma

  2016cites this paper
• Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study

  2016cites this paper
• Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier

  2016cites this paper
• Ultrasound-induced opening of the blood-brain barrier to enhance temozolomide and irinotecan delivery: an experimental study in rabbits.

  2016cites this paper
• Emerging Applications of Therapeutic Ultrasound in Neuro-oncology: Moving Beyond Tumor Ablation.

  2016cites this paper
• Glioma

  2015cites this paper
• Focused ultrasound-induced blood–brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study

  2015influential citation
• Current Therapy for Brain Tumors

  2015cites this paper
• Focused ultrasound with microbubbles increases temozolomide delivery in U87 transfected mice.

  2015cites this paper
• Blood–Brain Barrier and CNS Malignancy

  2014cites this paper
• Cannulation of the internal carotid artery in mice: a novel technique for intra-arterial delivery of therapeutics.

  2014cites this paper
• Pharmacodynamic and Therapeutic Investigation of Focused Ultrasound-Induced Blood-Brain Barrier Opening for Enhanced Temozolomide Delivery in Glioma Treatment

  2014cites this paper
• Opening of the blood-brain barrier with an unfocused ultrasound device in rabbits.

  2013cites this paper
• Novel therapeutic delivery approaches in development for pediatric gliomas.

  2013cites this paper
• The prognosis of anaplastic astrocytoma with radiologic necrosis mimicking glioblastoma

  2013cites this paper
• Focused Ultrasound-Induced Blood–Brain Barrier Opening to Enhance Temozolomide Delivery for Glioblastoma Treatment: A Preclinical Study

  2013cites this paper
• A new method of quantitatively assessing the opening of the blood-brain barrier in murine animal models.

  2012cites this paper
• Chapter 7 – Chemotherapy for Brain Tumors

  2012cites this paper
• Superselective intra-arterial cerebral infusion of novel agents after blood-brain disruption for the treatment of recurrent glioblastoma multiforme: a technical case series.

  2012cites this paper
• 41 – Primary central nervous system lymphoma

  2012cites this paper
• Textbook of interventional neurology

  2011cites this paper
• Intra-Arterial Chemotherapy for Malignant Gliomas: A Critical Analysis

  2011cites this paper
• Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma

  2011cites this paper
• Systemic low-molecular weight drug delivery to pre-selected neuronal regions

  2011cites this paper
• Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article.

  2011cites this paper
• Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment.

  2010cites this paper
• Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment.

  2010cites this paper
• Balloon-Assisted Superselective Intra-Arterial Cerebral Infusion of Bevacizumab for Malignant Brainstem Glioma

  2010cites this paper
• NEURO-OPHTHALMIC COMPLICATIONS OF CHEMOTHERAPY

  2010cites this paper
• Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma.

  2009cites this paper
• Age-dependent vascular changes induced by status epilepticus in rat forebrain: implications for epileptogenesis.

  2009cites this paper
• Pleomorphic malignant fibrous histiocytoma: response of bone, lung, and brain metastases to chemotherapy

  2008cites this paper
• Central nervous system tumors.

  2007cites this paper
• Reply: Complexities in the association of human blood^brain barrier disruption with seizures: importance of patient population and method of disruption

  2007cites this paper
• Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy.

  2007cites this paper
• Levels and distribution of BCNU in GBM tumors following intratumoral injection of DTI-015 (BCNU-ethanol).

  2007cites this paper
• The role of the blood-brain barrier and multidrug transporters in pharmacoresistant epilepsy : studies in a rat model for temporal lobe epilepsy

  2007cites this paper
• Enhanced Disruption of the Blood Brain Barrier by Intracarotid Mannitol Injection During Transient Cerebral Hypoperfusion in Rabbits

  2007influential citation
• Tripeptidyl-peptidase I in health and disease

  2006cites this paper
• Neuro-oncology index and review (adult primary brain tumors)

  2006cites this paper
• Clinical Pharmacology of Brain Tumor Chemotherapy

  2006cites this paper
• The Blood–Brain Barrier and Epilepsy

  2006influential citation
• Comparison of the blood-brain barrier and liver penetration of acridine antitumor drugs

  2004cites this paper
• Drug transport at the blood-brain barrier and the choroid plexus.

  2004cites this paper
• Osmotic blood-brain barrier disruption and chemotherapy in the treatment of high grade malignant glioma: patient series and literature review

  2004influential citation
• Brain and plasma pharmacokinetics and anticancer activities of cyclophosphamide and phosphoramide mustard in the rat

  2004cites this paper
• Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?

  2004cites this paper
• Chemotherapy administered in conjunction with osmotic blood-brain barrier modification in patients with brain metastases

  2004influential citation
• Observations on exsudation of fibronectin, fibrinogen and albumin in the brain after carotid infusion of hyperosmolar solutions

  2004cites this paper
• Structural changes in the rat brain after carotid infusions of hyperosmolar solutions

  2004cites this paper
• Preirradiation ifosfamide, carboplatin and etoposide (ICE) for the treatment of high-grade astrocytomas in children

  2003cites this paper
• Preirradiation ifosfamide, carboplatin, and etoposide (ICE) for the treatment of high-grade astrocytomas in children

  2003cites this paper
• Mixing during Intravertebral Arterial Infusions in an in vitro Model

  2002cites this paper
• Is intra-arterial chemotherapy useful in high-grade gliomas?

  2002cites this paper
• Phase I trial of lobradimil (RMP-7) and carboplatin in children with brain tumors

  2001cites this paper
• Methotrexate concentration in cerebrospinal fluid of the space created by tumor removal.

  2000cites this paper
• The blood-brain barrier and oncology: new insights into function and modulation.

  2000cites this paper
• Preirradiation ifosfamide, carboplatin, and etoposide for the treatment of anaplastic astrocytomas and glioblastoma multiforme: a phase II study.

  2000cites this paper
• Cytotoxic chemotherapy: Advances in delivery, pharmacology, and testing

  2000cites this paper
• Prognostic factors in recurrent glioblastoma multiforme and anaplastic astrocytoma treated with selective intra-arterial chemotherapy.

  2000cites this paper
• Chemotherapy in Malignant Gliomas

  2000cites this paper
• Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood‐brain barrier for the treatment of patients with malignant brain tumors

  2000cites this paper
• Angiogenesis in Health and Disease

  2000cites this paper
• Insulin‐like growth factor I is the key growth factor in serum that protects neuroblastoma cells from hyperosmotic‐induced apoptosis

  2000cites this paper
• Current therapy for brain tumors: back to the future.

  1999cites this paper
• Dose-Related Increases in Cerebrospinal Fluid Concentrations of Methotrexate in a Postoperative Patient with Glioblastoma

  1999cites this paper
• Chemotherapy for adults with malignant glioma.

  1999cites this paper
• Blood-brain barrier permeability to small and large molecules.

  1999cites this paper
• Clinical Presentation, Diagnosis, and Pharmacotherapy of Patients with Primary Brain Tumors

  1999cites this paper
• The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.

  1998cites this paper
• A phase I study of intravenous RMP-7 with carboplatin in patients with progression of malignant glioma.

  1998cites this paper
• Technique of, and complications attributable to, repeated hyperosmotic blood-brain barrier disruption in dogs.

  1998cites this paper
• Unexpected in vitro chemosensitivity of malignant gliomas to 4-hydroxyperoxycyclophosphamide (4-HC)

  1998cites this paper
• Current Treatment Modalities for Brain Tumor

  1998cites this paper
• Radiolabeling of epidermal growth factor with 99mTc and in vivo localization following intracerebral injection into normal and glioma-bearing rats.

  1997cites this paper